RAPTOR protocol: hybrid in-person + telehealth physical therapy services for Osteoarthritis

University of Pittsburgh, Pittsburgh, PA
OsteoarthritisRAPTOR protocol: hybrid in-person + telehealth physical therapy services - Other
Eligibility
18+
All Sexes

Study Summary

This trial is testing a new way to provide rehabilitation for people with knee pain, using a combination of in-person and remote (telerehabilitation) interventions. The goal is to see if this is feasible and effective.

Eligible Conditions
  • Osteoarthritis of the Knee

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

5 Primary · 6 Secondary · Reporting Duration: Through study completion, which is anticipated to take approximately 1 year.

Week 10
Clinically Important Improvement on ONE Functional Outcome Measure
Functional outcome measure: 30-second chair stand test
Functional outcome measure: 40-meter fast-paced walk test
Functional outcome measure: 6-minute walk
Functional outcome measure: Change from baseline in KOOS (Knee Injury and Osteoarthritis Outcome Score) to Post-Treatment
Functional outcome measure: Timed Up and Go (TUG)
Functional outcome measure: Timed stair climb test
Week 10
Telehealth Usability Questionnaire
Year 1
Recruitment Target
Study-Related Adverse Events / Serious Adverse Events
Visit Attendance (75% or higher)

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

RAPTOR Physical Therapy Intervention
1 of 1

Experimental Treatment

27 Total Participants · 1 Treatment Group

Primary Treatment: RAPTOR protocol: hybrid in-person + telehealth physical therapy services · No Placebo Group · N/A

RAPTOR Physical Therapy Intervention
Other
Experimental Group · 1 Intervention: RAPTOR protocol: hybrid in-person + telehealth physical therapy services · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, which is anticipated to take approximately 1 year.

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,647 Previous Clinical Trials
16,311,722 Total Patients Enrolled
12 Trials studying Osteoarthritis
4,758 Patients Enrolled for Osteoarthritis
University of Pittsburgh Medical Center Rehabilitation InstituteUNKNOWN
Allyn Bove, DPT, PhDPrincipal InvestigatorUniversity of Pittsburgh

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What is the scope of participants for this medical experiment?

"Yes, according to clinicaltrials.gov this trial is still enrolling patients. This research was first listed on December 20th 2021 and has recently been revised on January 6th 2022. 27 individuals are being sought by a single location for the study." - Anonymous Online Contributor

Unverified Answer

Are there still opportunities available to join this trial?

"According to the data found on clinicaltrials.gov, this particular medical trial is currently recruiting participants. It was initially posted on December 20th 2021 and last amended January 6th 2022." - Anonymous Online Contributor

Unverified Answer

What primary outcomes is this clinical trial attempting to measure?

"The primary aim of the study is to assess any Study-Related Adverse Events / Serious Adverse Events that may arise in a period of one year. Secondary objectives center around measuring functional outcomes from baseline, such as: 6 minute walk test (measuring meters walked at self-selected pace), KOOS subscale scores for pain, activities of daily living and quality of life; and 30 second chair stand tests (number of times participant can rise/sit in given time)." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.